医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

DCAT Launches Networking Event in Barcelona to Serve Expanding Global Membership

2016年08月16日 PM08:30
このエントリーをはてなブックマークに追加


 

ROBBINSVILLE, N.J.

With over 40 percent of its new member companies headquartered outside North America, the Drug, Chemical & Associated Technologies Association (DCAT) is introducing a special networking event at Casa Llotja de Mar in Barcelona, Spain on Wednesday, October 5, 2016 from 6:00 to 8:30 pm. The networking reception, DCAT After The Show, is scheduled immediately following CPhI Worldwide so that members will have plenty of time to connect with colleagues and establish new business contacts before attending late-night customer events.

“With the growth of the organization’s membership globally, the DCAT leadership expanded the networking opportunities for members who may not attend DCAT Week, our flagship event held annually in New York City,” said DCAT President Dr. Folker Ruchatz, Corporate Vice President, Consumer Health Care Operations and Third Party Management at Boehringer Ingelheim GmbH. “DCAT is a business development association for the global pharmaceutical manufacturing industry and we are committed to helping our members expand their network of industry contacts.”

Registration for DCAT After The Show is $79.00 USD and includes food, beverage and transportation to Casa Llotja de Mar, a magnificent 14th century historic landmark on Barcelona’s waterfront. To learn more about this exciting opportunity visit www.dcat.org/AfterTheShow .

About DCAT

DCAT is a 501(c)6 not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. www.dcat.org

View source version on businesswire.com: http://www.businesswire.com/news/home/20160816005152/en/

CONTACT

Drug, Chemical & Associated Technologies Association
Erin
Sanders, 609-208-1888
Director of Communications
esanders@dcat.org
or
Brandwidth
Solutions LLC
Debra Harrsch, 215-997-8575
dharrsch@brandwidthsolutions.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease